title: Potential pitfalls in intraoperative parathyroid hormone measurements during parathyroid surgery.
abstract: BACKGROUND
  The outcome of parathyroid surgery is often not clear for at least 24 h after the operation. A frozen section does not always distinguish between an adenoma and hyperplasia. Minimally invasive surgical techniques are being refined, so the need for perioperative assurance about the completeness of surgery has increased. The value of intraoperative parathyroid hormone (PTH) measurements in 26 surgical cases undergoing parathyroidectomy has been evaluated.
  
  
  METHODS
  Twenty-one patients were diagnosed as having primary hyperparathyroidism, including two patients with multiple endocrine neoplasia type I (MEN I). Five patients had tertiary hyperparathyroidism, including one patient with X-linked hypophosphataemia and four with renal hyperparathyroidism (RHPT). Blood samples were taken at the onset of surgery, at the time of tumour resection and at 5-min intervals following removal of the tumour. PTH was measured using a PTH Turbo assay on the DPC Immulite analyser.
  
  
  RESULTS
  Current practice suggests that the PTH concentration should fall to less than 50% of the pre-incision value or to less than 50% of the level at the time of tumour resection (time equals zero). PTH levels were therefore monitored at 5-min intervals following removal of the tumour. In most of the case studies PTH followed the suggested pattern, but not when further exploration was warranted to determine if another adenoma was present. In some cases the PTH levels fell by the appropriate margin to deem the procedure a success but at 10 min post-gland excision the PTH began to rise again. Further exploration was required to confirm the continued source of PTH.
  
  
  CONCLUSIONS
  We recommend that intraoperative PTH measurements continue until at least 15 min post-gland removal in cases of suspected single-gland disease. A decline in PTH concentration to at least 50% of the pre-incision or time of gland resection levels should be observed. If the PTH remains elevated or rises again after an appropriate decrease in levels, then multigland disease or ectopic sources should be considered. Caution is recommended in interpreting intraoperative PTH measurements to ensure complete success of the surgical procedure.
authors.affiliation: Clinical Biochemistry, University College Hospitals London, 60 Whitfield Street, London W1T 4EU, UK. ian.phillips@uclh.nhs.uk
authors.forename: I J
authors.initials: IJ
authors.lastname: Phillips
authors.forename: T R
authors.initials: TR
authors.lastname: Kurzawinski
authors.forename: J W
authors.initials: JW
authors.lastname: Honour
mesh_terms: D000236:Adenoma / Q000601:surgery; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006801:Humans; D007432:Intraoperative Period; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000031:analogs & derivatives* / Q000097:blood; D010282:Parathyroid Neoplasms / Q000601:surgery; D016105:Parathyroidectomy; D013997:Time Factors
chemical_list: C470125:PTH protein, human; D010281:Parathyroid Hormone